Department of Veterinary Medicine and Animal Science, University of Milan, Via dell'Università 6, 26900, Lodi, LO, Italy.
Department of Life Science, University of Modena and Reggio Emilia, Via Campi 103, 41125, Modena, Italy.
Anal Bioanal Chem. 2022 Sep;414(23):6841-6853. doi: 10.1007/s00216-022-04249-3. Epub 2022 Aug 2.
The objective of the current research was to develop a liquid chromatography-MS (LC-MS) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone, cortisone, α-cortolone, β-cortolone, allotetrahydrocortisol, 5α-dihydrocortisol, tetrahydrocortisol, allotetrahydrocortisone, 5β-dihydrocortisol, tetrahydrocortisone) in human urine. Due to its optimal performance, a linear ion trap operating in ESI negative ion mode was chosen for the spectrometric analysis, performing MS and MS experiments. The method was validated for limit of detection (LOD) and limit of quantification (LOQ) (0.01 ng mL and 0.05 ng mL, for all compounds, respectively), intra- and inter-day precision (CV = 1.4-9.2% and CV = 3.6-10.4%, respectively), intra- and inter-day accuracy (95-110%), extraction recovery (65-95%), linearity (R2 > 0.995), and matrix effect that was absent for all molecules. Additionally, for each compound, the percentage of glucuronated conjugates was estimated. The method was successfully applied to the urine (2 mL) of 50 healthy subjects (25 males, 25 females). It was also successfully employed on urine samples of two patients with Cushing syndrome and one with Addison's disease. This analytical approach could be more appropriate than commonly used determination of urinary free cortisol collected in 24-h urine. The possibility of considering the differences and relationship between cortisol and its metabolites allows analytical problems related to quantitative analysis of cortisol alone to be overcome. Furthermore, the developed method has been demonstrated as efficient for antidoping control regarding the potential abuse of corticosteroids, which could interfere with the cortisol metabolism, due to negative feedback on the hypothalamus-hypophysis-adrenal axis. Lastly, this method was found to be suitable for the follow-up of prednisolone that was particularly important considering its pseudo-endogenous origin and correlation with cortisol metabolism.
本研究的目的是建立一种液相色谱-质谱联用(LC-MS)方法,用于测定人尿中游离皮质醇及其 15 种内源性代谢物(6β-羟基皮质醇、20α-二氢皮质醇、20α-二氢皮质酮、20β-二氢皮质醇、20β-二氢皮质酮、泼尼松龙、皮质酮、α-考的松龙、β-考的松龙、全四氢皮质醇、5α-二氢皮质醇、四氢皮质醇、全四氢皮质酮、5β-二氢皮质醇、四氢皮质酮)。由于其最佳性能,选择线性离子阱在 ESI 负离子模式下进行质谱分析,进行 MS 和 MS 实验。该方法对检测限(LOD)和定量限(LOQ)(分别为所有化合物的 0.01ng mL 和 0.05ng mL)、日内和日间精密度(CV=1.4-9.2%和 CV=3.6-10.4%)、日内和日间准确度(95-110%)、提取回收率(65-95%)、线性(R2>0.995)和基质效应进行了验证,所有分子均不存在基质效应。此外,还估计了每种化合物的葡萄糖醛酸结合物的百分比。该方法成功应用于 50 名健康受试者(25 名男性,25 名女性)的尿液(2mL)。它还成功应用于 2 例库欣综合征患者和 1 例艾迪生病患者的尿液样本。与通常在 24 小时尿液中收集的游离皮质醇相比,这种分析方法可能更合适。考虑皮质醇与其代谢物之间的差异和关系的可能性,可以克服单独定量分析皮质醇时遇到的分析问题。此外,所开发的方法已被证明可用于反兴奋剂控制,因为皮质激素的潜在滥用会对下丘脑-垂体-肾上腺轴产生负反馈,从而干扰皮质醇代谢。最后,该方法被发现适用于泼尼松龙的随访,这在考虑到其拟内源性起源及其与皮质醇代谢的相关性时尤为重要。